Plasma levels of irisin in children with idiopathic premature adrenarche

 
 
 
  • Abstract
  • Keywords
  • References
  • PDF
  • Abstract


    Background: Premature adrenarche (PA) is characterized by presence of isolated pubic and/or axillary hair, acne and body odor before age 8(9) in girls (boys). These individuals are at increased risk of developing insulin resistance, metabolic syndrome and polycistic ovarian syndrome. Irisin seems to have an active role in the metabolism of carbohydrates and lipids, however little is known about this hormone in PA.

    Objective: To analyze irisin levels in children diagnosed with PA and its relationship with their body composition.

    Methodology: Exploratory cross-sectional study that evaluated 15 children with PA and 15 matched controls (C). Anthropometric data were measured: height, weight, waist circumference (WC) and triceps skinfold. Fasting blood glucose(G), insulin(I), 17OHP, total cholesterol, LDL, HDL, triglycerides, DHEA-S, 25(OH)D and irisin levels were determined.

    Results: The levels (mean±SEM) of triglycerides [99±14, 8mg/dl (C); 68±9, 1mg/dl (AP)] and 25(OH) D [26±0, 9ng/ml(C); 30.2±1.6ng/ml (AP)] were significantly different between the groups. WC above p90 and G/ I<7 were found in 6.7% of the C group versus 33.3% and 20% of the PA group, respectively.

    Conclusions: PA children presented a lower G/I and a higher waist WC compared to the C group, suggesting an increased risk of metabolic disease. Irisin levels were not different between the groups. The significantly higher levels of TGs from the C group may be related to their reduced levels of 25(OH) D, which may also have masked differences in irisin levels. This study suggests that determination of vitamin D levels may be necessary to evaluate metabolic data, based on the significant frequency of this hormone insufficiency/deficiency in the pediatric population.


  • Keywords


    Body Composition; Children; Irisin; Premature Adrenarche; Vitamin D.

  • References


      [1] Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Højlund K, Gygi SP & Spiegelman BM (2012). A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature (London) 81, 463-468. https://doi.org/10.1038/nature10777.

      [2] Cavalier É, Mismetti V, Souberbielle JC (2014). Evalua-tion of circulating irisin levels in healthy young individuals after a single 100,000 IU vitamin D dose. Annales d'endocrinologie 75, 162-164. https://doi.org/10.1016/j.ando.2014.05.005.

      [3] Chang CL, Huang SY, Soong YK, Cheng PJ, Wang CJ & Liang IT (2014). Circulating irisin and glucose-dependent insu-linotropic peptide are associated with the development of polycystic ovary syndrome. The Journal of clinical endocrinology and me-tabolism 9, 2539-2548. https://doi.org/10.1210/jc.2014-1180.

      [4] Chen N, Li Q, Liu J, Jia S (2016), Irisin, an exercise-induced myokine as a metabolic regulator: an updated narrative review. Diabetes/metabolism research and reviews. 32, 51-59. https://doi.org/10.1002/dmrr.2660.

      [5] Ferran K, Paiva IA, Garcia L dos S, GAMA M de P, Guimarães MM (2011) Isolated premature pubarche: report of anthropometric and metabolic profile of a Brazilian cohort of girls. Hormone research in pædiatrics 75, 367-373. https://doi.org/10.1159/000324107.

      [6] Gamas L, Matafome P & Seiça R (2015). Irisin and Myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk. Journal of Diabetes Research 2015, 0-8. https://doi.org/10.1155/2015/359159.

      [7] García-Fontana B, Reyes-García R, Morales-Santana S, Ávila-Rubio V, Muñoz-Garach A, Rozas-Moreno P & Muñoz-Torres M (2015). Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state? Endocrine 52, 54-62. https://doi.org/10.1007/s12020-015-0758-8.

      [8] Hecksteden A, Wegmann M, Steffen A, Kraushaar J, Morsch A, Ruppenthal S, Kaestner L & Meyer T (2013). Irisin and exercise training in humans – Results from a randomized controlled training trial. BMC medicine 5, 235. https://doi.org/10.1186/1741-7015-11-235.

      [9] Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, & Weaver CM (2011). Evaluation, treatment, and prevention of vitamin d deficiency: an endocrine society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 96, 1911-1930. https://doi.org/10.1210/jc.2011-0385.

      [10] Hou N, Han F & Sun X (2015). The relationship be-tween circulating irisin levels and endothelial function in lean and obese subjects. Clinical endocrinology 83, 339-343. https://doi.org/10.1111/cen.12658.

      [11] Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE & Mantzoros CS (2012). FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. MRNA expression and circulating con-centrations in response to weight loss and exercise. Metabolism: clinical and experimental 61, 725-738. https://doi.org/10.1016/j.metabol.2012.09.002.

      [12] Huh JY, Siopi A, Mougios V, Park KH, Mantzoros CS (2015). Irisin in response to exercise in humans with and without metabolic syndrome. The Journal of clinical endocrinology and metabolism 100, 453-457. https://doi.org/10.1210/jc.2014-2416.

      [13] Ibáñez L, Dimartino-Nardi J, Potau N & Saenger P (2000). Premature adrenarche normal variant or forerunner of adult disease? Endocrine Reviews 21, 671-696. https://doi.org/10.1210/edrv.21.6.0416.

      [14] Idkowiak J, Lavery GG, Dhir V, Barrett TG, Stewart PM, Krone N & Arlt W (2011). Premature adrenarche: novel les-sons from early onset androgen excess. European journal of endo-crinology/European Federation of Endocrine Societies.165, 189-207. https://doi.org/10.1530/EJE-11-0223.

      [15] Korth-Schutz S, Levine LS & New MI (1976). Serum androgens in normal prepubertal and pubertal children with preco-cious adrenarche. The Journal of Clinical Endocrinology & Me-tabolism 42, 117-124. https://doi.org/10.1210/jcem-42-1-117.

      [16] Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L, Srbecky M, Imrich R, Kyselovicova O,Belan V, Jelok I, Wolfrum C, Klimes I, Krssak M, Zemkova E, Gasperikova D, Ukropec J & Ukropcova B (2014), Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitrostudies. The Journal of physiology 592, 1091-1107. https://doi.org/10.1113/jphysiol.2013.264655.

      [17] Matsuda S & Kitagishi Y (2013). Peroxisome Prolifera-tor-Activated Receptor and Vitamin D Receptor Signaling Path-ways in Cancer Cells. Cancers (Basel) 5, 1261–1270. https://doi.org/10.3390/cancers5041261.

      [18] Moon HS, Dincer F & Mantzoros CS (2013). Pharmaco-logical concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines. Metabolism: clinical and experimental. 62, 1131-1136 https://doi.org/10.1016/j.metabol.2013.04.007.

      [19] Oron T, Lebenthal Y, Vries L, Yackobovitch-Gavan M, Phillip M & Lazar L (2012). Interrelationship of extent of preco-cious adrenarche in appropriate for gestational age girls with clinical outcome. The Journal of Pediatrics 60, 308-313. https://doi.org/10.1016/j.jpeds.2011.08.009.

      [20] Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, Tsoukas MA, Geladari EV,Huh JY, Dincer F, Davis CR, Crowell JA & Mantzoros CS (2013). Circulating irisin in relation to insulin resistance and the metabolic syndrome. The Journal of clinical endocrinology and metabolism 98, 4899-4907. https://doi.org/10.1210/jc.2013-2373.

      [21] Park S, Kim da S, Kang S (2016). Vitamin D deficiency impairs glucose-stimulated insulin secretion and increases insulin resistance by reducing PPAR-γ expression in non obese Type 2 diabetic rats. The Journal of Nutritional Biochemistry 27, 257-265. https://doi.org/10.1016/j.jnutbio.2015.09.013.

      [22] Peters BSE, Oliveira PMP & Fisberg M (2013). Calcium and vitamin D intake by the population of children and teenagers. Pediatria Moderna 249, 51-56.

      [23] Rana KS, Arif M, Hill EJ, Aldred S, Nagel DA, Nevill A, Randeva HS, Bailey CJ, Bellary S & Brown JE (2014). Plasma irisin levels predict telomere length in healthy adults. Age (Dordr) 36, 995-1001. https://doi.org/10.1007/s11357-014-9620-9.

      [24] Sanchis-Gomar F, Alis R, Pareja-Galeano H, Sola E, Victor VM, Rocha M, Hernández-Mijares A & Romagnoli M (2014), Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients. Endocrine 46, 674-677. 7. https://doi.org/10.1007/s12020-014-0170-9.

      [25] Santos BR (2011). Estudo da associação entre polimorfismos do gene do receptor de vitamina D (VDR) e do SNP-71 A/G do gene 17 beta- hidroxiesteróide desidrogenase tipo 5 (HSD17B5) e variáveis clínicas, hormonais e metabólicas em pacientes com pubarca precoce e controles. pp. 1-91. Federal University of Rio Grande do Sul, BR.

      [26] Schumacher MA, Chinnam N, Ohashi T, Shah RS & Erickson HP (2013). The structure of irisin reveals a novel inter-subunit β-sheet fibronectin type III (FNIII) dimer: implications for receptor activation. The Journal of biological chemistry 288, 33738-33744. https://doi.org/10.1074/jbc.M113.516641.

      [27] Sopher AB, Jean AM, Zwany SK, Winston DM, Pomer-anz CB, Bell JJ, , McMahon DJ, Hassoun A, Fennoy I & Oberfield SE (2011). Bone age advancement in prepubertal children with obesity and premature adrenarche: possible potentiating factors. Obesity 19, 1259-1264. https://doi.org/10.1038/oby.2010.305.

      [28] Stengel A, Hofmann T, Goebel-stengel M, Elbelt U, Kobelt P & Klapp BF (2013). Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides 39, 25-30. https://doi.org/10.1016/j.peptides.2012.11.014.

      [29] Tang H, Yu R, Liu S, Huwatibieke B, Li Z, Zhang W (2016). Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling. EBioMedicine 6, 139-148. https://doi.org/10.1016/j.ebiom.2016.02.041.

      [30] Utriainen P, Laakso S, Liimatta J, Jääskeläinen J, Vouti-lainen R (2015). Premature adrenarche--a common condition with variable presentation. Hormone Research in Pediatrics 83, 221-231. https://doi.org/10.1159/000369458.

      [31] Valtueña J1, Breidenassel C, Folle J & González-Gross M (2011). Retinol, β-carotene, α-tocopherol and vitamin D status in European adolescents; regional differences an variability: A review. Nutrición hospitalaria 26, 280-288.

      [32] Xiong XQ, Chen D, Sun HJ, Ding L, Wang JJ, Chen Q, Li YH, Zhou YB, Han Y, Zhang F, Gao XY, Kang YM & Zhu GQ (2015). FNDC5 overexpression and irisin ameliorate glu-cose/lipid metabolic derangements and enhance lipolysis in obesity. Biochimica et biophysica acta. 1852, 1867-1875. https://doi.org/10.1016/j.bbadis.2015.06.017.

      [33] Yang Z, Chen X, Chen Y & Zhao Q (2015). Decreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice. International journal of clinical and experimental pa-thology 8, 6490-6497.


 

View

Download

Article ID: 6699
 
DOI: 10.14419/ijans.v5i2.6699




Copyright © 2012-2015 Science Publishing Corporation Inc. All rights reserved.